CDH1 and ovarian cancer: It is interesting to note, however, that mechanistic studies proved that in ovarian cancer cells, E-cadherin may serve not only as an intercellular adhesion molecule, but also as an upstream regulator that triggers downstream kinase activation, this explaining why E-cadherin is always expressed during ovarian tumor development and progression [33, 37].